scholarly article | Q13442814 |
P50 | author | Nan Laird | Q6962218 |
Augusto A Litonjua | Q42572197 | ||
John E Hokanson | Q89513456 | ||
P2093 | author name string | David A Lomas | |
Edwin K Silverman | |||
James D Crapo | |||
Michael H Cho | |||
Peter J Castaldi | |||
Terri H Beaty | |||
Amund Gulsvik | |||
Per Bakke | |||
Wayne Anderson | |||
COPDGene and Eclipse Investigators | |||
P2860 | cites work | Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin alpha8beta1 in the embryonic kidney | Q24291483 |
Sub-picomolar relaxin signalling by a pre-assembled RXFP1, AKAP79, AC2, beta-arrestin 2, PDE4D3 complex | Q24293265 | ||
Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II | Q24338780 | ||
Genome-wide association study identifies five loci associated with lung function | Q24629653 | ||
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function | Q24633262 | ||
Database resources of the National Center for Biotechnology Information | Q24644775 | ||
Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis | Q24645989 | ||
Molecular genetics of successful smoking cessation: convergent genome-wide association study results | Q24653819 | ||
The natural history of chronic airflow obstruction | Q24674578 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema | Q28205534 | ||
A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis | Q28507626 | ||
Genotype imputation | Q29614590 | ||
Glutathione transferases | Q29616501 | ||
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. | Q33419815 | ||
A genome-wide association study of pulmonary function measures in the Framingham Heart Study | Q33419839 | ||
The COPD genetic association compendium: a comprehensive online database of COPD genetic associations | Q33559787 | ||
Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms | Q34686548 | ||
MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. | Q37383035 | ||
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response | Q44032299 | ||
Pulmonary function between 6 and 18 years of age. | Q46340194 | ||
The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. | Q53572756 | ||
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) | Q57955885 | ||
P433 | issue | 6 | |
P921 | main subject | genome-wide association study | Q1098876 |
chronic obstructive pulmonary disease | Q199804 | ||
P304 | page(s) | 1147-1153 | |
P577 | publication date | 2011-06-09 | |
P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
P1476 | title | The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility | |
P478 | volume | 45 |
Q47639018 | A Genome-wide Association Study in Hispanics/Latinos Identifies Novel Signals for Lung Function. The Hispanic Community Health Study/Study of Latinos. |
Q55214049 | A candidate gene identification strategy utilizing mouse to human big-data mining: "3R-tenet" in COPD genetic research. |
Q35860362 | A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry |
Q63432937 | AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers |
Q28387051 | APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema |
Q42271746 | Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study |
Q36842527 | Advanced glycation endproducts and their receptor in different body compartments in COPD |
Q54522045 | Association of five genetic variants with chronic obstructive pulmonary disease susceptibility and spirometric phenotypes in a Chinese Han population. |
Q34522806 | Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Chinese Han population: a case-control study |
Q53286287 | Association of lung function genes with chronic obstructive pulmonary disease. |
Q36176931 | CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland |
Q26777324 | Candidate genes for COPD: current evidence and research |
Q38636068 | Chronic Obstructive Pulmonary Disease Genetics: A Review of the Past and a Look Into the Future |
Q91810031 | Cohort Profile: Extended Cohort for E-health, Environment and DNA (EXCEED) |
Q36105702 | Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. |
Q34004971 | Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease |
Q35087187 | Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans |
Q37431463 | Copy number variation of the beta-defensin genes in europeans: no supporting evidence for association with lung function, chronic obstructive pulmonary disease or asthma |
Q36968835 | Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12. |
Q90076687 | Exposure to lipopolysaccharide (LPS) reduces contractile response of small airways from GSTCD-/- mice |
Q45768914 | Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese |
Q24337095 | GSTCD and INTS12 regulation and expression in the human lung |
Q24630805 | Genes and chronic obstructive pulmonary disease |
Q38974166 | Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects. |
Q39851159 | Genetic Variants in IL6R and ADAM19 are Associated with COPD Severity in a Mexican Mestizo Population. |
Q86038893 | Genetic linkage analysis identifies Pas1 as the common locus modulating lung tumorigenesis and acute inflammatory response in mice |
Q30274832 | Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis |
Q28596713 | Genetic regulation of expression of leukotriene A4 hydrolase |
Q38700796 | Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice |
Q38760182 | Genetic variants affecting cross-sectional lung function in adults show little or no effect on longitudinal lung function decline |
Q43792387 | Genetic variants in HHIP are associated with FEV1 in subjects with chronic obstructive pulmonary disease |
Q39032868 | Genome-Wide Interaction Analysis of Air Pollution Exposure and Childhood Asthma with Functional Follow-up |
Q30420166 | Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction |
Q38169066 | Lessons from ECLIPSE: a review of COPD biomarkers |
Q36320879 | Lung function associated gene Integrator Complex subunit 12 regulates protein synthesis pathways |
Q96306279 | Measures of lung function and their relationship with advanced glycation end-products |
Q42235129 | Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. |
Q36123192 | Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank |
Q64250562 | Pathological Implications of Receptor for Advanced Glycation End-Product () Gene Polymorphism |
Q27025295 | RAGE: a new frontier in chronic airways disease |
Q54757715 | Receptor for advanced glycation end products and soluble receptor for advanced glycation end products: a balancing act in chronic obstructive pulmonary disease? |
Q36392496 | Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation |
Q51524555 | Susceptibility for cigarette smoke-induced DAMP release and DAMP-induced inflammation in COPD. |
Q35999518 | Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases. |
Q43779676 | Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease |
Q36257364 | Targeted Sequencing of Lung Function Loci in Chronic Obstructive Pulmonary Disease Cases and Controls |
Q39312857 | The emerging role of NPNT in tissue injury repair and bone homeostasis. |
Q38896877 | Traditional and emerging indicators of cardiovascular risk in chronic obstructive pulmonary disease. |
Q34562154 | Variants in the 15q24/25 locus associate with lung function decline in active smokers |
Q38026994 | What can genetics tell us about the cause of fixed airflow obstruction? |
Q33553057 | Whole exome re-sequencing implicates CCDC38 and cilia structure and function in resistance to smoking related airflow obstruction. |
Search more.